Rxcurve
HCPCS J2515 · per 50 MG

Pentobarbital sodium inj

This code is not in the latest file (4Q26). It was last listed in 1Q23.

Payment limit per 50 MG, by effective quarter, 1Q21 to 1Q23. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J2515

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
1Q23 $22.60 +$2.23 50 MG Pentobarbital sodium inj v1, posted December 6, 2023
4Q22 $20.37 −$5.80 50 MG Pentobarbital sodium inj v1, posted June 22, 2023
3Q22 $26.17 +$1.863 50 MG Pentobarbital sodium inj v1, posted June 9, 2023
2Q22 $24.307 +$0.179 50 MG Pentobarbital sodium inj v1, posted December 14, 2022
1Q22 $24.128 −$2.283 50 MG Pentobarbital sodium inj v1, posted June 8, 2022
4Q21 $26.411 −$1.209 50 MG Pentobarbital sodium inj v1, posted June 2, 2022
3Q21 $27.62 −$6.286 50 MG Pentobarbital sodium inj v1, posted June 2, 2022
2Q21 $33.906 +$2.121 50 MG Pentobarbital sodium inj v1, posted March 1, 2022
1Q21 $31.785 – 50 MG Pentobarbital sodium inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files